COMPANY
|
|
Velos Launches Free Internet Clinical Research Service
San Francisco, CA - October 4, 2001 - Velos, a
leading healthcare software and internet services vendor, today
launched a transformational investigator-centered, internet-based
clinical trials management service called Velos eResearch. Velos
eResearch is a comprehensive clinical trials management service that
supports the administration, study execution, and communications
challenges of the underserved clinical investigator
community.
“The healthcare industry is plagued by long
software acquisition cycles,” notes John McIlwain, President and CEO
of Velos. “Approvals for capital investments and grants take months
or sometimes years. Software vendors build high sales and support
costs into their pricing. Many end-users simply do without. Velos is
first-to-market with an entirely new model for providing critical
healthcare information services using internet
technology.”
“Velos already counts among its planned
subscribers investigators at four of the top ten medical centers as
ranked by U.S. News and World Report,” continued Mr. McIlwain.
“What’s particularly unique about Velos eResearch is that the
service involves minimal implementation effort and major components
are free for individual investigators and small investigator
teams.”
The volume of clinical research has increased
dramatically over the last ten years and is expected to continue to
grow substantially over the next ten years. The vast majority of
clinical research today is done with pen and paper. This has begun
to change among industry sponsors, who are increasingly investing in
Remote Data Capture systems and other technologies that are expected
to shorten the elapsed time to trial database lock. Numerous
vendors, large and small, have emerged to serve study sponsors.
However, the investigator activities that lead up to trial data
submission, such as protocol design, budgeting, IRB approvals,
patient recruitment, patient scheduling, and task management,
account for the bulk of the controllable elapsed time in clinical
trials. Solving these problems requires getting useful information
technology into the hands of investigators, quickly and
inexpensively.
Velos eResearch ushers in a new generation of
internet-based research capabilities that fundamentally improve the
pervasiveness and efficiency of clinical research, both internally
and with trial sponsors. Velos eResearch enables better investigator
recruitment and patient enrollment, better communication and
transfer of protocol and data between investigators, the IRB and the
participating sites, and better task/time management, thereby
reducing the elapsed time and effort required to execute clinical
trials. And, it’s FREE for individual and small investigator
teams.
“Velos is in the fortunate position of having been
able to invest significant time and money working side-by-side with
investigators and their support staffs,” commented Priti Sahai, MD,
Velos eResearch Product Manager. “We then built, from scratch, a
pure, HIPAA compliant internet solution that requires minimum set-up
and maintenance, is productive in minutes and hours, not weeks and
months, and requires only a web browser for access.”
About Velos
Velos is a leading designer and developer of next-generation
healthcare information systems. Velos develops, markets, and
supports an integrated suite of clinical, administrative, and
financial products for renal, transplant, cardiology and research.
Velos’ internet services and turnkey solutions address the
information needs of specialty healthcare providers and clinical
researchers. An internet-based software product, Velos eResearch is
designed to expedite the research process by supporting the
administration and execution of clinical research and trials.
Additional information on Velos eResearch may be found at http://www.velos.com/ . Velos is privately held with
headquarters in Silicon Valley.
This press release contains
forward-looking statements that are subject to risks and
uncertainties that could cause actual results to differ materially
from those set forth in the forward-looking statements. Actual
results may differ materially from those projected. These
forward-looking statements represent Velos judgment as of the date
of this release. Velos disclaims any intent or obligation to update
these forward-looking statements.
Additional information
regarding Velos may be obtained by contacting Madalynne Chapman
(510-608-5744) or mchapman@velos.com.
For a seven minute product tour, click: Velos eResearch Product Tour
|
|
